BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 36185251)

  • 1. Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report.
    Yoshida T; Yaegashi H; Toriumi R; Kadomoto S; Iwamoto H; Izumi K; Kadono Y; Ikeda H; Mizokami A
    Front Oncol; 2022; 12():912490. PubMed ID: 36185251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pembrolizumab for a patient with metastatic castration-resistant prostate cancer with microsatellite instability-high.
    Fujiwara M; Komai Y; Yuasa T; Numao N; Yamamoto S; Fukui I; Yonese J
    IJU Case Rep; 2020 Mar; 3(2):62-64. PubMed ID: 32743472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience of Pembrolizumab Administration in A Patient with Castration-Resistant Microsatellite Instability-High Prostate Cancer].
    Takasawa T; Amano T; Himeno M; Imao T
    Hinyokika Kiyo; 2024 Feb; 70(2):51-54. PubMed ID: 38447945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis.
    Mosalem O; Tan W; Bryce AH; Dronca RS; Childs DS; Pagliaro LC; Orme JJ; Kase AM
    Prostate Cancer Prostatic Dis; 2024 Feb; ():. PubMed ID: 38341460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report.
    Inakami K; Fujita N; Iguchi C; Enomoto Y; Minohata J; Sata A; Miyagawa Y; Yanagisawa T; Saitoh T; Nomura T; Sawai Y; Takahara K; Kasugai T; Shiba E
    J Med Case Rep; 2024 May; 18(1):214. PubMed ID: 38689362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durable response to pembrolizumab in microsatellite instability-high advanced adrenocortical carcinoma.
    Senda M; Hashimoto K; Shindo T; Kobayashi K; Tanaka T; Masumori N
    IJU Case Rep; 2023 Nov; 6(6):382-385. PubMed ID: 37928286
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Okubo K; Narita S; Koizumi A; Takahashi Y; Sagehashi R; Mori K; Sobu R; Sato H; Kashima S; Kobayashi M; Yamamoto R; Nara T; Numakura K; Saito M; Nanjo H; Habuchi T
    Case Rep Oncol; 2023; 16(1):621-627. PubMed ID: 37900835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful pembrolizumab treatment for microsatellite instability-high thymoma: A case report.
    Kaneko T; Sekine A; Komatsu S; Otoshi R; Haga S; Tagami Y; Kaneko T; Ogura T
    Respir Investig; 2024 Apr; 62(4):517-519. PubMed ID: 38631274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare case of unresectable, microsatellite instability-high hepatocellular carcinoma and an examination of the tumor microenvironment.
    Tomiyama T; Itoh S; Toshida K; Morinaga A; Fujimoto-Kosai Y; Tomino T; Kurihara T; Nagao Y; Morita K; Harada N; Kohashi K; Eguchi Y; Oda Y; Mori M; Yoshizumi T
    Int Cancer Conf J; 2023 Jan; 12(1):81-86. PubMed ID: 36605838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eldest gastric cancer patient with high microsatellite instability responding to pembrolizumab.
    Wakasugi A; Sasaki A; Okamoto R; Motomura Y
    Int Cancer Conf J; 2023 Jan; 12(1):59-62. PubMed ID: 36605839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prominent response to platinum-based chemotherapy in a patient with
    Daimon T; Kosaka T; Hongo H; Aimono E; Nakamura K; Mikami S; Nishihara H; Oya M
    IJU Case Rep; 2021 Jul; 4(4):216-219. PubMed ID: 34258530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience and Lessons Learned in the Treatment of Transforming Small Cell Neuroendocrine Carcinoma of the Prostate: A Case Report and Literature Review.
    Song B; Luo Y; Li Q; Pan H; Li D
    Case Rep Oncol; 2024; 17(1):247-255. PubMed ID: 38357684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined DNA repair defects in testicular metastasis from prostate cancer sensitize to immune checkpoint blockade.
    Vlachostergios PJ
    Curr Urol; 2021 Dec; 15(4):234-237. PubMed ID: 35069089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete metabolic response of metastatic castration-resistant neuroendocrine carcinoma of the prostate after treatment with RRx-001 and reintroduced platinum doublets.
    Ojemuyiwa M; Zeman K; Spira A; Oronsky B; Ray C; Trepel JB; Lee MJ; Onyiuke I; Brzezniak C
    Clin Case Rep; 2018 Dec; 6(12):2478-2481. PubMed ID: 30564353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From biology to the clinic - exploring liver metastasis in prostate cancer.
    Ni X; Wei Y; Li X; Pan J; Fang B; Zhang T; Lu Y; Ye D; Zhu Y
    Nat Rev Urol; 2024 Apr; ():. PubMed ID: 38671281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of whole-body diffusion-weighted magnetic resonance imaging in the management of treatment-related neuroendocrine prostate cancer.
    Kurashina R; Kijima T; Okazaki A; Fuchizawa H; Suzuki I; Sakamoto K; Betsunoh H; Fukabori Y; Yashi M; Kamai T
    IJU Case Rep; 2021 Mar; 4(2):69-73. PubMed ID: 33718807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful pembrolizumab treatment of microsatellite instability-high intrahepatic cholangiocarcinoma: A case report.
    Ikeda Y; Ono M; Ohmori G; Ameda S; Yamada M; Abe T; Fujii S; Fujita M; Maeda M
    Clin Case Rep; 2021 Apr; 9(4):2259-2263. PubMed ID: 33936676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell analysis of castration-resistant prostate cancers to identify potential biomarkers for diagnosis and prognosis of neuroendocrine prostate cancer.
    Hong YC; Hu TY; Hsu CS; Yeh WW; Wong WZ; Shen TW; Chang CH; Hua K; Tung CY; Peng YC; Huang WJ; Chang PC; Lin TP
    Am J Cancer Res; 2023; 13(10):4560-4578. PubMed ID: 37970364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of relapsing aseptic meningitis under excellent tumor response to pembrolizumab in microsatellite instability-high recurrent endometrial cancer.
    Noguchi D; Seki T; Kubonoya Y; Komazaki H; Ozone H; Yanaihara N; Takano H; Okamoto A
    Gynecol Oncol Rep; 2021 Nov; 38():100885. PubMed ID: 34926766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate carcinoma with neuroendocrine differentiation successfully treated by early detection with imaging examination.
    Kobayashi M; Hagiwara M; Yamashita H; Ohbu M; Irie A
    IJU Case Rep; 2020 Nov; 3(6):282-285. PubMed ID: 33163926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.